DUBLIN, Nov 23, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Pharmacogenomics (PGx) Market Analysis & Trends - Technology, Therapeutic Applications - Forecast to 2025" report to their offering.
"Global Pharmacogenomics (PGx) Market Analysis & Trends - Technology (Polymerase Chain Reaction (PCR), Microarray and Sequencing), Therapeutic Applications (Cardiovascular Diseases (CVD), Central Nervous System (CNS), Cancer/Oncology and Infectious Diseases) - Forecast to 2025"
Depending on the ecosystem players the market is segmented by service providers, pharmaceuticals companies and diagnostic test companies.
By technology the market is divided into Polymerase Chain Reaction (PCR), microarray, sequencing and other technologies. Sequencing segment is further segmented into pyrosequencing, Next-Generation Sequencing (NGS) and Sanger sequencing. Other technologies are further classified into electrophoresis and mass spectrometry.
Based on therapeutic applications the market is categorized into Cardiovascular Diseases (CVD), Central Nervous System (CNS), cancer/oncology, infectious diseases and other diseases.
This industry report analyzes the global markets for Pharmacogenomics (PGx) across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.
- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2025, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2025
- Market opportunities and recommendations for new investments
- Abbott Laboratories
- Affymetrix, Inc.
- Assurex Health, Inc
- Illumina, Inc.
- Laboratory Corporation of America Holdings
- Myriad Genetics, Inc.
- Pathway Genomics
- Pfizer, Inc
- Qiagen, Inc.
- Roche Holding Ag-Br
- Teva Pharmaceutical Industries Ltd.
- Thermo Fisher Scientific
- Transgenomic, Inc.
1 Market Outline
2 Executive Summary
3 Market Overview
4 Pharmacogenomics (PGx) Market, By Ecosystem Players
5 Pharmacogenomics (PGx) Market, By Technology
6 Pharmacogenomics (PGx) Market, By Therapeutic Applications
7 Pharmacogenomics (PGx) Market, By Geography
8 Key Player Activities
9 Leading Companies
For more information about this report visit http://www.researchandmarkets.com/research/6mvfgm/global
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets